Precision Medicine and Obesity
- PMID: 33518159
- PMCID: PMC7863578
- DOI: 10.1016/j.gtc.2020.10.005
Precision Medicine and Obesity
Abstract
The highly variable response to obesity therapies justifies the search for treatment strategies that are best suited to individual patients to enhance their effectiveness and tolerability via precision medicine. Precision medicine development in recent years has been driven by the emergence of powerful methods to characterize patients ("omic" assays). Current available information has revealed that there are numerous intermediary processes that contribute to obesity and have provided a framework for partially comprehending the mechanisms behind the heterogeneity of obesity and its clinical consequences. Some of these processes have or are currently being targeted to individualize obesity therapy with some success.
Keywords: Nutrigenomics; Obesity; Personalized nutrition; Phenotype; Precision medicine.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure M.D. Hurtado A has nothing to disclose. A. Acosta is a stockholder in Gila Therapeutics and Phenomix Sciences; and serves as a consultant for Rhythm Pharmaceuticals and General Mills.
References
-
- Organization WH. 2016.
-
- Waters HaGM. America’s Obesity Crisis: the Health and Economic Costs of excess weight. The Milken Institute; October 26, 2018 2018.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
